Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
64 results:

  • 1. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
    Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
    Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety of high-dose rate (hdr) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series.
    Thomas H; Chen JJ; Abdul-Baki H; Sabbagh A; Shaheen H; Chau OW; Malik N; Ayoub A; Hassanzadeh C; Hsu IC; Mohamad O
    Brachytherapy; 2024; 23(2):173-178. PubMed ID: 38160102
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Organ and Function Preservation in Gastrointestinal Malignancies.
    Sur R; Than NW; Taggar A; Sripadam R; Sun Myint A
    Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):524-532. PubMed ID: 37357120
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
    Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
    Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
    [No Abstract]    [Full Text] [Related]  

  • 5. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.
    Fokas E; Glynne-Jones R; Fleischmann M; Piso P; Tselis N; Ghadimi M; Hofheinz RD; Rödel C
    Cancer Treat Rev; 2023 Jan; 112():102490. PubMed ID: 36463667
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (hdr) brachytherapy of liver metastases.
    Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
    Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
    Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High dose rate brachytherapy in the management of anal cancer: A review.
    Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
    Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring gata3.
    Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
    Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 11. Radiotherapeutic treatment options for oligotopic malignant liver lesions.
    Wust P; Beck M; Dabrowski R; Neumann O; Zschaeck S; Kaul D; Modest DP; Stromberger C; Gebauer B; Ghadjar P
    Radiat Oncol; 2021 Mar; 16(1):51. PubMed ID: 33726751
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
    Moe K; Maa HC; Pei D; Liang YJ; Chen YL
    Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
    Rouanet P; Rivoire M; Gourgou S; Lelong B; Rullier E; Jafari M; Mineur L; Pocard M; Faucheron JL; Dravet F; Pezet D; Fabre JM; Bresler L; Balosso J; Taoum C; Lemanski C
    J Surg Oncol; 2021 Jan; 123(1):299-310. PubMed ID: 33098678
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Advanced design, simulation, and dosimetry of a novel rectal applicator for contact brachytherapy with a conventional hdr
    Bellezzo M; Fonseca GP; Voncken R; Verrijssen AS; Van Beveren C; Roelofs E; Yoriyaz H; Reniers B; Van Limbergen EJ; Berbée M; Verhaegen F
    Brachytherapy; 2020; 19(4):544-553. PubMed ID: 32386884
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.
    Duque AS; Corradini S; Kamp F; Seidensticker M; Streitparth F; Kurz C; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Fonseca GP; Landry G
    Radiat Oncol; 2020 Mar; 15(1):60. PubMed ID: 32151255
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
    Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
    Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
    Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A systematic review comparing radiation toxicity after various endorectal techniques.
    Verrijssen AS; Opbroek T; Bellezzo M; Fonseca GP; Verhaegen F; Gerard JP; Sun Myint A; Van Limbergen EJ; Berbee M
    Brachytherapy; 2019; 18(1):71-86.e5. PubMed ID: 30396854
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
    Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ultrasound-assisted catheter placement in CT-guided hdr brachytherapy for the local ablation of abdominal malignancies: Initial experience.
    Damm R; El-Sanosy S; Omari J; Damm R; Hass P; Pech M; Powerski M
    Rofo; 2019 Jan; 191(1):48-53. PubMed ID: 30308690
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.